These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 25687649)
1. Characterization of the transcriptional activation domains of human TEF3-1 (transcription enhancer factor 3 isoform 1). Qiao C; Jiang Y; Deng C; Huang Z; Teng K; Chen L; Liu X Arch Biochem Biophys; 2015 Mar; 569():54-61. PubMed ID: 25687649 [TBL] [Abstract][Full Text] [Related]
2. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor. Liu X; Zhao D; James L; Li J; Zeng H FASEB J; 2011 Apr; 25(4):1188-97. PubMed ID: 21169383 [TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of TEF3-1 promotes cell cycle progression and angiogenesis in cancer. Teng K; Deng C; Xu J; Men Q; Lei T; Di D; Liu T; Li W; Liu X Oncotarget; 2016 Mar; 7(12):13827-41. PubMed ID: 26885617 [TBL] [Abstract][Full Text] [Related]
4. The novel axis of YAP1, transcription enhancer factor 3 and Down Syndrome Candidate Region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors. Cui P; Liu X; Zhao K; Hou S; Chen C; Zhao D; Zeng H Microvasc Res; 2020 May; 129():103955. PubMed ID: 31733305 [TBL] [Abstract][Full Text] [Related]
5. The activity of the activation function 2 of the human hepatocyte nuclear factor 4 (HNF-4alpha) is differently modulated by F domains from various origins. Suaud L; Formstecher P; Laine B Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):161-9. PubMed ID: 10229671 [TBL] [Abstract][Full Text] [Related]
6. Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells. Liu X; Zhao D; Qin L; Li J; Zeng H J Biol Chem; 2008 Dec; 283(49):34159-67. PubMed ID: 18840614 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human. Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226 [TBL] [Abstract][Full Text] [Related]
8. Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. Chuvpilo S; Avots A; Berberich-Siebelt F; Glöckner J; Fischer C; Kerstan A; Escher C; Inashkina I; Hlubek F; Jankevics E; Brabletz T; Serfling E J Immunol; 1999 Jun; 162(12):7294-301. PubMed ID: 10358178 [TBL] [Abstract][Full Text] [Related]
9. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"? Seipel K; Georgiev O; Gerber HP; Schaffner W Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625 [TBL] [Abstract][Full Text] [Related]
10. Structural studies on a protein-binding zinc-finger domain of Eos reveal both similarities and differences to classical zinc fingers. Westman BJ; Perdomo J; Matthews JM; Crossley M; Mackay JP Biochemistry; 2004 Oct; 43(42):13318-27. PubMed ID: 15491138 [TBL] [Abstract][Full Text] [Related]
11. Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain. Anbanandam A; Albarado DC; Nguyen CT; Halder G; Gao X; Veeraraghavan S Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17225-30. PubMed ID: 17085591 [TBL] [Abstract][Full Text] [Related]
12. The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors. Wissmüller S; Kosian T; Wolf M; Finzsch M; Wegner M Nucleic Acids Res; 2006; 34(6):1735-44. PubMed ID: 16582099 [TBL] [Abstract][Full Text] [Related]
13. Identification of residues critical for the function of the Vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis. Childers BM; Weber GG; Prouty MG; Castaneda MM; Peng F; Klose KE J Mol Biol; 2007 Apr; 367(5):1413-30. PubMed ID: 17320105 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein. Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942 [TBL] [Abstract][Full Text] [Related]
16. Identification of an N-terminal transcriptional activation domain within Brn3b/POU4f2. Martin SE; Mu X; Klein WH Differentiation; 2005 Feb; 73(1):18-27. PubMed ID: 15733064 [TBL] [Abstract][Full Text] [Related]
17. Nuclear factor of activated T cells 2 transactivation in mast cells: a novel isoform-specific transactivation domain confers unique FcepsilonRI responsiveness. Hock MB; Brown MA J Biol Chem; 2003 Jul; 278(29):26695-703. PubMed ID: 12738787 [TBL] [Abstract][Full Text] [Related]
18. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Maeda T; Gupta MP; Stewart AF Biochem Biophys Res Commun; 2002 Jun; 294(4):791-7. PubMed ID: 12061776 [TBL] [Abstract][Full Text] [Related]
19. Crystal structure of MEF2A core bound to DNA at 1.5 A resolution. Santelli E; Richmond TJ J Mol Biol; 2000 Mar; 297(2):437-49. PubMed ID: 10715212 [TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of Grainyhead-like epithelial transactivator (GET-1), a novel mammalian Grainyhead-like factor. Kudryavtseva EI; Sugihara TM; Wang N; Lasso RJ; Gudnason JF; Lipkin SM; Andersen B Dev Dyn; 2003 Apr; 226(4):604-17. PubMed ID: 12666198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]